These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24752346)

  • 1. Impact of anti-centromere antibodies on pulmonary function test results in patients with systemic sclerosis without established or suspected pulmonary disease.
    Gunn J; Pauling JD; McHugh NJ
    Clin Rheumatol; 2014 Jun; 33(6):869-71. PubMed ID: 24752346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibody.
    Steen VD; Lucas M; Fertig N; Medsger TA
    J Rheumatol; 2007 Nov; 34(11):2230-5. PubMed ID: 17937469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis.
    Kampolis C; Plastiras S; Vlachoyiannopoulos P; Moyssakis I; Tzelepis G
    Scand J Rheumatol; 2008; 37(4):278-83. PubMed ID: 18612928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis.
    Becker MO; Kill A; Kutsche M; Guenther J; Rose A; Tabeling C; Witzenrath M; Kühl AA; Heidecke H; Ghofrani HA; Tiede H; Schermuly RT; Nickel N; Hoeper MM; Lukitsch I; Gollasch M; Kuebler WM; Bock S; Burmester GR; Dragun D; Riemekasten G
    Am J Respir Crit Care Med; 2014 Oct; 190(7):808-17. PubMed ID: 25181620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated DLco/VA reduction in systemic sclerosis patients: a new patient subset?
    Corzo P; Pros A; Martinez-Llorens J; Molina L; Ling SF; Balcells E
    Clin Rheumatol; 2018 Dec; 37(12):3365-3371. PubMed ID: 30368639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial lung disease increases mortality in systemic sclerosis patients with pulmonary arterial hypertension without affecting hemodynamics and exercise capacity.
    Michelfelder M; Becker M; Riedlinger A; Siegert E; Drömann D; Yu X; Petersen F; Riemekasten G
    Clin Rheumatol; 2017 Feb; 36(2):381-390. PubMed ID: 28028682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating factors influencing screening for pulmonary hypertension in systemic sclerosis: does disparity between available guidelines influence clinical practice?
    Pauling JD; McHugh NJ
    Clin Rheumatol; 2012 Feb; 31(2):357-61. PubMed ID: 21912881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case control study.
    Overbeek MJ; Groepenhoff H; Voskuyl AE; Smit EF; Peeters JW; Vonk-Noordegraaf A; Spreeuwenberg MD; Dijkmans BC; Boonstra A
    Respir Res; 2008 Oct; 9(1):68. PubMed ID: 18828919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts.
    Gladue H; Steen V; Allanore Y; Saggar R; Saggar R; Maranian P; Berrocal VJ; Avouac J; Meune C; Trivedi M; Khanna D
    J Rheumatol; 2013 Oct; 40(10):1706-11. PubMed ID: 23950183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New centromere autoantigens identified in systemic sclerosis using centromere protein microarrays.
    Song G; Hu C; Zhu H; Wang L; Zhang F; Li Y; Wu L
    J Rheumatol; 2013 Apr; 40(4):461-8. PubMed ID: 23418382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status.
    Kane GC; Varga J; Conant EF; Spirn PW; Jimenez S; Fish JE
    Respir Med; 1996 Apr; 90(4):223-30. PubMed ID: 8736656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-centromere antibodies in a large cohort of systemic sclerosis patients: comparison between immunofluorescence, CENP-A and CENP-B ELISA.
    Mahler M; You D; Baron M; Taillefer SS; Hudson M; ; Fritzler MJ
    Clin Chim Acta; 2011 Oct; 412(21-22):1937-43. PubMed ID: 21756890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease.
    Perosa F; Favoino E; Favia IE; Vettori S; Prete M; Corrado A; Cantatore FP; Valentini G
    Medicine (Baltimore); 2016 Jun; 95(25):e3931. PubMed ID: 27336883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in systemic sclerosis-pulmonary arterial hypertension by serum autoantibody status in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) Registry.
    Hinchcliff M; Khanna S; Hsu VM; Lee J; Almagor O; Chang RW; Steen V; Chung L;
    Semin Arthritis Rheum; 2015 Dec; 45(3):309-14. PubMed ID: 26210782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticentromere antibody positive Sjögren's Syndrome: a retrospective descriptive analysis.
    Bournia VK; Diamanti KD; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Res Ther; 2010; 12(2):R47. PubMed ID: 20302639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis.
    Morrisroe KB; Stevens W; Nandurkar H; Prior D; Thakkar V; Roddy J; Zochling J; Sahhar J; Tymms K; Sturgess A; Major G; Kermeen F; Hill C; Walker J; Nash P; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-133-7. PubMed ID: 24564981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.
    Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M
    Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
    Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
    Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies.
    Spencer-Green G; Alter D; Welch HG
    Am J Med; 1997 Sep; 103(3):242-8. PubMed ID: 9316557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.